Ilaris 150 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DX25F6AFK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $128,275
Award facts
- Contract value 100% obligated
- $128,275.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency issued a $128,275.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for ILARIS 150 mg/ml vial pharmaceutical product. This delivery order, awarded on September 9, 2025, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. The delivery order carries no set-aside designation and is scheduled for completion by September 30, 2025, with performance occurring at the vendor's facility in Park Ridge, Illinois.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a critical supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Under the Defense Logistics Agency's SPE2DB program, the company leverages its position to deliver specialized pharmaceutical products including oncology treatments, vaccines, injections, and other critical medications supporting military health system operations globally. This delivery order for ILARIS, an immunosuppressive biologic used in rheumatoid arthritis and other inflammatory conditions, reflects the company's ongoing role supplying specialized therapeutics to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6AFK?
SPE2DX25F6AFK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 9, 2025.
How much is contract SPE2DX25F6AFK worth?
The government has obligated $128,275 on SPE2DX25F6AFK.
Is contract SPE2DX25F6AFK an order under another contract?
Yes. SPE2DX25F6AFK is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFK competed?
The extent of competition for SPE2DX25F6AFK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award